BioSpace News Archive

Policy

Inventor Of “LessDrops,” Surgical Eyedrop, Wins Return Of Patent From Harrow Health

Novel Drug Solutions, LLC and Eye Care Northwest, PA, announce the return of their unrestricted patent rights to several awarded and pending USA and international patents previously controlled by Harrow Health, Inc..

December 10, 2019
·
3 min read
Biotech Bay

Personalis, Inc. to Present at ESMO Immuno-Oncology Congress 2019

ImmunoID NeXT™ is the first platform to enable comprehensive analysis of both a tumor and its immune microenvironment from a single sample.

December 10, 2019
·
2 min read
Genetown

Constellation Pharmaceuticals Announces Pricing of Public Offering of Common Stock

The offering is expected to close on December 13, 2019, subject to customary closing conditions.

December 10, 2019
·
5 min read
Drug Development

Ascentage Pharma Releases Updated Data of its Novel BCR-ABL Inhibitor, HQP1351, in an Oral Presentation Nominated for “Best of ASH”

At the 61st American Society of Hematology Annual Meeting

December 10, 2019
·
5 min read
Drug Development

CStone announces enrollment target reached in the global Phase III VOYAGER trial of avapritinib in Chinese patients with third-line GIST

On July 10, 2019, CStone announced the dosing of the first patient in China for the VOYAGER trial.

December 10, 2019
·
6 min read
Business

Greg Adams named Chairman, Chief Executive Officer, Kaiser Foundation Health Plan and Hospitals

Kaiser Permanente is a nonprofit organization serving more than 12.2 million members and generating more than $82 billion in annual revenue.

December 10, 2019
·
3 min read
Deals

Rocket Pharmaceuticals Prices Public Offering of Common Stock - Dec. 11, 2019

Rocket Pharmaceuticals, Inc. announces the pricing of an underwritten public offering of 3,820,000 shares of its common stock at a public offering price of $22.25 per share.

December 10, 2019
·
5 min read
Drug Development

ASH Roundup: Bristol-Myers Squibb, bluebird bio, Oryzon and More

As the 61st American Society of Hematology Annual Meeting wrapped up in Orlando, Florida, there were hundreds of studies and results presented. Here’s a look at some.

December 10, 2019
·
3 min read
·
Mark Terry
Business

Sanofi CEO Unveils New Strategy That Does Not Include Diabetes Research

Despite having one of the best-selling insulin products on the market, Sanofi is exiting diabetes and cardiovascular research and development in favor of more lucrative areas, particularly cancer research.

December 10, 2019
·
3 min read
·
Alex Keown
FDA

FDA Gives Thumbs-up to EtectRx’s Wireless Smart Pills

The company calls the system the first and only “ingestible event marker to transmit digital messages” from inside the body to a receiver without need for direct skin contact.

December 10, 2019
·
2 min read
·
Mark Terry